Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Clinical trial NCT07426484 · RECRUITING
Trial details
- NCT number
- NCT07426484
- Sponsor
- Dana-Farber Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-23
- Primary completion
- 2030-12-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.